Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
OXYCODONE-HAMELN (Hameln Pharma Pty Ltd)
Product name
OXYCODONE-HAMELN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
121 (255 working days)
Active ingredients
oxycodone hydrochloride
Registration type
New generic medicine
Indication
OXYCODONE-HAMELN (solution for injection) is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.